Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades
Sarepta Says FDA Postpones Advisory Committee Meeting to Review Eteplirsen Due to Severe Weather Storm in the Washington D.C.
Related PPO
Stocks Hitting 52-Week Highs
Earnings Scheduled For March 4, 2015

Analysts at Goldman Sachs upgraded Team Health Holdings (NYSE: TMH) from “neutral” to “conviction buy.” The target price for Team Health has been raised from $33 to $43. Team Health's stock closed at $36.75 yesterday.

Analysts at Topeka Capital upgraded Polypore International (NYSE: PPO) from “hold” to “buy.” The target price for Polypore has been raised from $37 to $46. Polypore's shares closed at $39.13 yesterday.

JP Morgan upgraded CenturyLink (NYSE: CTL) from “neutral” to “overweight.” The target price for CenturyLink is set to $38. CenturyLink's shares closed at $35.06 yesterday.

Jefferies upgraded Ulta Salon, Cosmetics & Fragrance (NASDAQ: ULTA) from “hold” to “buy.” The target price for Ulta Salon has been raised from $85 to $100. Ulta Salon's shares closed at $82.00 yesterday.

Posted-In: top upgradesUpgrades Analyst Ratings


Related Articles (CTL + PPO)

View Comments and Join the Discussion!